These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 29453318)

  • 1. Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance.
    Ha JR; Ahn R; Smith HW; Sabourin V; Hébert S; Cepeda Cañedo E; Im YK; Kleinman CL; Muller WJ; Ursini-Siegel J
    Mol Cancer Res; 2018 May; 16(5):894-908. PubMed ID: 29453318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.
    Ursini-Siegel J; Hardy WR; Zheng Y; Ling C; Zuo D; Zhang C; Podmore L; Pawson T; Muller WJ
    Oncogene; 2012 Nov; 31(48):5038-44. PubMed ID: 22286768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
    Im YK; Najyb O; Gravel SP; McGuirk S; Ahn R; Avizonis DZ; Chénard V; Sabourin V; Hudson J; Pawson T; Topisirovic I; Pollak M; St-Pierre J; Ursini-Siegel J
    Cancer Res; 2018 Sep; 78(17):4826-4838. PubMed ID: 29930100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
    Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
    J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
    Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
    Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
    Ahn R; Sabourin V; Ha JR; Cory S; Maric G; Im YK; Hardy WR; Zhao H; Park M; Hallett M; Siegel PM; Pawson T; Ursini-Siegel J
    Cancer Res; 2013 Jul; 73(14):4521-32. PubMed ID: 23695548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.
    Ahn R; Sabourin V; Bolt AM; Hébert S; Totten S; De Jay N; Festa MC; Young YK; Im YK; Pawson T; Koromilas AE; Muller WJ; Mann KK; Kleinman CL; Ursini-Siegel J
    Nat Commun; 2017 Mar; 8():14638. PubMed ID: 28276425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
    Landry M; Pomerleau V; Saucier C
    Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
    Ursini-Siegel J; Hardy WR; Zuo D; Lam SH; Sanguin-Gendreau V; Cardiff RD; Pawson T; Muller WJ
    EMBO J; 2008 Mar; 27(6):910-20. PubMed ID: 18273058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.
    Vanderlaan RD; Hardy WR; Kabir MG; Pasculescu A; Jones N; deTombe PP; Backx PH; Pawson T
    Circ Res; 2011 Jan; 108(2):184-93. PubMed ID: 21148430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor.
    Woldt E; Matz RL; Terrand J; Mlih M; Gracia C; Foppolo S; Martin S; Bruban V; Ji J; Velot E; Herz J; Boucher P
    J Biol Chem; 2011 May; 286(19):16775-82. PubMed ID: 21454706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
    Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
    Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ShcA adaptor protein is a critical regulator of breast cancer progression.
    Ursini-Siegel J; Muller WJ
    Cell Cycle; 2008 Jul; 7(13):1936-43. PubMed ID: 18604176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen.
    Nicholson PR; Empereur S; Glover HR; Dilworth SM
    EMBO J; 2001 Nov; 20(22):6337-46. PubMed ID: 11707405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial ShcA docking interactions support diversity in tissue morphogenesis.
    Hardy WR; Li L; Wang Z; Sedy J; Fawcett J; Frank E; Kucera J; Pawson T
    Science; 2007 Jul; 317(5835):251-6. PubMed ID: 17626887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
    Ursini-Siegel J; Cory S; Zuo D; Hardy WR; Rexhepaj E; Lam S; Schade B; Jirstrom K; Bjur E; Piccirillo CA; Denardo D; Coussens LM; Brennan DJ; Gallagher WM; Park M; Pawson T; Hallett M; Muller WJ
    Cancer Res; 2010 Oct; 70(20):7776-87. PubMed ID: 20924104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ShcA Adaptor Protein Promotes Nephrin Endocytosis and Is Upregulated in Proteinuric Nephropathies.
    Martin CE; Petersen KA; Aoudjit L; Tilak M; Eremina V; Hardy WR; Quaggin SE; Takano T; Jones N
    J Am Soc Nephrol; 2018 Jan; 29(1):92-103. PubMed ID: 29018139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of STS-1 as a novel ShcA-binding protein.
    van der Meulen T; Swarts S; Fischer W; van der Geer P
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1334-1339. PubMed ID: 28690151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.